Skip to content

Cesarean Section Defect Mechanism and Transvaginal Repair

A Prospective Randomized Controlled Study on the Efficacy and Safety of Different Suture Methods for the Transvaginal Repair of Cesarean Section Defect and the Exploration of the Underlying Molecular Mechanism of the Defect Occurrence

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05643703
Enrollment
300
Registered
2022-12-09
Start date
2022-12-20
Completion date
2026-11-20
Last updated
2022-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Scar Defect; Transvaginal Diverticulum Resection

Brief summary

Background and aims: Cesarean section defect (CSD) can cause abnormal uterine bleeding or impaired fertility, which severely impaire the quality of life in women of pregnant age. For women with moderate or severe CSD, surgery can be performed. The objectives of this study is to compare the efficacy and safety of different suture methods in the treatment of transvaginal diverticulum resection, and the underlying mechanism of CSD occurrence. Methods: The patients diagnosed with CSD will be enrolled and randomizely assigned into suture method A and suture method. The fresh isolated tissue and swab of different sites in genital tract will be collected for NGS, microbiome, metabonomics and proteomics analysis. Hypothesis: The menstruation will be analyzed at different following time. The other clinical information will be also collected, including age at surgery, skin-to skin operative time, estimated blood loss (EBL). The perioperative complications, postoperative hopitalization, cost for hospital stay, blasser/intestinal function recovery will also be compared between two gorup. The outcome of fertility will be compared, such as the premature birth, premature rupture of membranes, and rupture of uterus. The clinical manifestation related to CSD and recurrence will be followed. Besides, the underlying mechanism will be analyzed.

Interventions

PROCEDURESuture method

One-layered Suture: Single layer intermittent suture; Two-layered Suture:Single layer intermittent suture plus U type reinforcement stitching

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years, premenopausal female; 2. The scar is the transverse incision of the lower segment of the uterus (one or more times); 3. The following abnormal uterine bleeding occurred after cesarean section: prolonged menstruation/endless menstruation ≥ 14 days, menstrual bleeding; 4. Transvaginal three-dimensional ultrasound/pelvic MRI plain scan showed that the thickness of residual muscular layer at the top of diverticulum was less than 3 mm; 5. The effect of drug treatment is poor, and it is difficult to adhere to long-term drug treatment or surgical treatment; 6. HGB \> 100g/L before operation; 7. Hysteroscopy excluded endometrial lesions; 8. The patient or family members can understand the study protocol and voluntarily participate in the study, and provide written informed consent.

Exclusion criteria

1. The data of cesarean section is not complete, and the previous cesarean section method cannot be determined; 2. Abnormal uterine bleeding caused by endocrine disorders (thyroid dysfunction, luteal insufficiency), endometrial lesions, uterine fibroids, gynecological tumors, blood system diseases, pelvic infections, intrauterine devices, etc; 3. Infertility patients caused by female oviduct infertility, intrauterine adhesion infertility, uterine malformation, polycystic ovary syndrome, male infertility, etc; 4. Patients with other serious gynecological diseases and/or serious physical or psychological diseases; 5. Pregnancy (women of childbearing age were positive in pregnancy test at baseline or did not receive pregnancy test), and women in lactation; 6. Patients who are unable to complete the follow-up; 7. The patient or family members could not understand the conditions and objectives of the study and did not agree to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Prolongation of menstrual period3 month after surgeryPatients' subject description of the duration of menstrual period, which is defined as the first day of menstruation to the end day

Secondary

MeasureTime frameDescription
fertility outcomewithin 5 years after surgeryrecord the post-operative fertility outcome, including natural pregnancy or assisted reproduction, and the correspondence fertility outcome, such as premature birth, premature rupture of membranes, etc.

Other

MeasureTime frameDescription
objective measurement of caesarean scar diverticulumwithin 1 years after surgeryThe difference of different diameters of caesarean scar diverticulum before and after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026